DERIVES DE TETRAHYDRO-BENZO[D]AZEPINE UTILISES EN TANT QUE MODULATEURS DE GPR120

• 收藏
• 分享

专利权人:

CALDAN THERAPEUTICS LIMITED

发明人:

BROWN, JANE,CONNOLLY, STEPHEN,HANSEN, STEFFEN V. F.,MILNE, GAVIN,SHIMPUKADE, BHARAT,SMYTH, DON,THOMAS, GERARD,ULVEN, TROND,BRVAR, MATJAZ,RIGBY, AARON

申请号：

CA3057415

公开号：

CA3057415A1

申请日:

2018.03.26

申请国别(地区):

CA

年份:

2018

代理人:

摘要：

Novel tetrahydroisoquinoline and tetrahydrobenzazepine compounds of formula (I) capable of modulating the G-protein-coupled receptor GPR120, compositions comprising the compounds, and methods for their use for controlling insulin levelsin vivoand for the treatment of conditions such as of diabetes, inflammation, obesity and metabolic diseases. (I)

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/